Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-14-000035

Options or other derivatives

  • Chief Scientific Officer disposed of 20,000,002 shares (other)
  • Chief Scientific Officer acquired 5,697,710 shares (other)

From the SEC's structured data for this filing

Trades in this filing

NIGALAYE ASHOK G · Chief Scientific Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2014-10-17 Other disposition : show line 1 in the form Warrants −20,000,002 6,726,999 I
2014-10-17 Other acquisition : show line 2 in the form Warrants +5,697,710 10,122,043 D
Loading xslF345X03/primary_doc.xml…